512 related articles for article (PubMed ID: 23341308)
21. Pediatricians' intention to administer human papillomavirus vaccine: the role of practice characteristics, knowledge, and attitudes.
Kahn JA; Zimet GD; Bernstein DI; Riedesel JM; Lan D; Huang B; Rosenthal SL
J Adolesc Health; 2005 Dec; 37(6):502-10. PubMed ID: 16310128
[TBL] [Abstract][Full Text] [Related]
22. Relative contributions of parental intention and provider recommendation style to HPV and meningococcal vaccine receipt.
Eun TJ; Hanchate A; Fenton AT; Clark JA; Aurora MN; Drainoni ML; Perkins RB
Hum Vaccin Immunother; 2019; 15(10):2460-2465. PubMed ID: 30862301
[TBL] [Abstract][Full Text] [Related]
23. Prevalence and predictors of human papillomavirus vaccination in adolescent girls.
Palli SR; Mehta S; Aparasu RR
J Am Pharm Assoc (2003); 2012; 52(1):52-8. PubMed ID: 22257616
[TBL] [Abstract][Full Text] [Related]
24. Misinformation Drives Low Human Papillomavirus Vaccination Coverage in South African Girls Attending Private Schools.
Milondzo T; Meyer JC; Dochez C; Burnett RJ
Front Public Health; 2021; 9():598625. PubMed ID: 33681125
[No Abstract] [Full Text] [Related]
25. A model of health care provider decision making about HPV vaccination in adolescent males.
Alexander AB; Best C; Stupiansky N; Zimet GD
Vaccine; 2015 Aug; 33(33):4081-6. PubMed ID: 26143612
[TBL] [Abstract][Full Text] [Related]
26. Predictors of Human Papillomavirus Vaccine Completion Among Low-Income Latina/o Adolescents.
Gerend MA; Stephens YP; Kazmer MM; Slate EH; Reyes E
J Adolesc Health; 2019 Jun; 64(6):753-762. PubMed ID: 30777636
[TBL] [Abstract][Full Text] [Related]
27. Disparities in Provider Recommendation of Human Papillomavirus Vaccination for U.S. Adolescents.
Mohammed KA; Geneus CJ; Osazuwa-Peters N; Adjei Boakye E; Tobo BB; Burroughs TE
J Adolesc Health; 2016 Nov; 59(5):592-598. PubMed ID: 27506278
[TBL] [Abstract][Full Text] [Related]
28. Parent report of provider HPV vaccine communication strategies used during a randomized, controlled trial of a provider communication intervention.
Dempsey AF; Pyrzanowski J; Campagna EJ; Lockhart S; O'Leary ST
Vaccine; 2019 Feb; 37(10):1307-1312. PubMed ID: 30733088
[TBL] [Abstract][Full Text] [Related]
29. Provider perspectives on multilevel barriers to HPV vaccination.
Lake PW; Kasting ML; Christy SM; Vadaparampil ST
Hum Vaccin Immunother; 2019; 15(7-8):1784-1793. PubMed ID: 30779687
[TBL] [Abstract][Full Text] [Related]
30. Asking about human papillomavirus vaccination and the usefulness of registry validation: a study of young women recruited using Facebook.
Gunasekaran B; Jayasinghe Y; Brotherton JM; Fenner Y; Moore EE; Wark JD; Fletcher A; Tabrizi SN; Garland SM
Vaccine; 2015 Feb; 33(6):826-31. PubMed ID: 25444782
[TBL] [Abstract][Full Text] [Related]
31. Are there socioeconomic disparities in women having discussions on human papillomavirus vaccine with health care providers?
Wong KY; Do YK
BMC Womens Health; 2012 Oct; 12():33. PubMed ID: 23033931
[TBL] [Abstract][Full Text] [Related]
32. Acceptability of using standing orders to deliver human papillomavirus vaccines in the outpatient obstetrician/gynecologist setting.
Dempsey AF; Pyrzanowski J; Brewer S; Barnard J; Sevick C; O'Leary ST
Vaccine; 2015 Apr; 33(15):1773-9. PubMed ID: 25731788
[TBL] [Abstract][Full Text] [Related]
33. Moving forward: human papillomavirus vaccination and the prevention of cervical cancer.
Vetter KM; Geller SE
J Womens Health (Larchmt); 2007 Nov; 16(9):1258-68. PubMed ID: 18001182
[TBL] [Abstract][Full Text] [Related]
34. Human Papillomavirus Vaccination Knowledge, Barriers, and Recommendations Among Healthcare Provider Groups in the Western United States.
Ayres S; Gee A; Kim S; Hashibe M; Praag A; Kaiser D; Chang CP; Brandt HM; Kepka D
J Cancer Educ; 2022 Dec; 37(6):1816-1823. PubMed ID: 34236651
[TBL] [Abstract][Full Text] [Related]
35. Final analysis of a study assessing genital human papillomavirus genoprevalence in young Australian women, following eight years of a national vaccination program.
Garland SM; Cornall AM; Brotherton JML; Wark JD; Malloy MJ; Tabrizi SN;
Vaccine; 2018 May; 36(23):3221-3230. PubMed ID: 29724506
[TBL] [Abstract][Full Text] [Related]
36. Implementation of Strategies to Improve Human Papillomavirus Vaccine Coverage: A Provider Survey.
Walling EB; Dodd S; Bobenhouse N; Reis EC; Sterkel R; Garbutt J
Am J Prev Med; 2019 Jan; 56(1):74-83. PubMed ID: 30573149
[TBL] [Abstract][Full Text] [Related]
37. Caregiver and adolescent factors associated with delayed completion of the three-dose human papillomavirus vaccination series.
Widdice LE; Hoagland R; Callahan ST; Kahn JA; Harrison CJ; Pahud BA; Frey SE; Berry AA; Kotloff KL; Edwards KM; Mulligan MJ; Sudman J; Nakamura A; Bernstein DI
Vaccine; 2018 Mar; 36(11):1491-1499. PubMed ID: 29428177
[TBL] [Abstract][Full Text] [Related]
38. Providers' beliefs about the effectiveness of the HPV vaccine in preventing cancer and their recommended age groups for vaccination: Findings from a provider survey, 2012.
Berkowitz Z; Malone M; Rodriguez J; Saraiya M
Prev Med; 2015 Dec; 81():405-11. PubMed ID: 26598805
[TBL] [Abstract][Full Text] [Related]
39. Factors that Influence Healthcare Provider Recommendation of HPV Vaccination.
Btoush R; Kohler RK; Carmody DP; Hudson SV; Tsui J
Am J Health Promot; 2022 Sep; 36(7):1152-1161. PubMed ID: 35442819
[No Abstract] [Full Text] [Related]
40. HPV vaccination coverage of teen girls: the influence of health care providers.
Smith PJ; Stokley S; Bednarczyk RA; Orenstein WA; Omer SB
Vaccine; 2016 Mar; 34(13):1604-1610. PubMed ID: 26854907
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
